Literature DB >> 12109636

Malignant melanoma: treatments emerging, but early detection is still key.

Paul Masci1, Ernest C Borden.   

Abstract

Although we are beginning to develop treatment options for malignant melanoma, earlier recognition of potential primary melanomas remains the most effective way to increase survival in this highly malignant disease. This article reviews prominent risk factors for melanoma, key physical findings in at-risk patients, new melanoma staging guidelines, and recent and emerging therapy options.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109636     DOI: 10.3949/ccjm.69.7.529

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

1.  Calcaneal melanoma; our rare case and review of the literature.

Authors:  Karaiskos Ioannis; Palla Victoria; Pateras Ioannis; Stamatakos Michael
Journal:  Indian J Surg       Date:  2010-12-03       Impact factor: 0.656

Review 2.  Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

Authors:  Ernest C Borden
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-06       Impact factor: 7.638

3.  Guanine nucleotide exchange factor H1 can be a new biomarker of melanoma.

Authors:  Jie Shi; Bingyu Guo; Yu Zhang; Qiang Hui; Peng Chang; Kai Tao
Journal:  Biologics       Date:  2016-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.